Derek Bagley - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Derek Bagley's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Derek Bagley
Verified
Senior Editor, Endocrine News
Beats
air fryers, food processors smart thermostats, smart plugs blenders, smart lightsSmart speakers, coffee makers smart switches
Content
The Path of Kahn: Q&A with Barbara Kahn, MD, Recipient of the 2025 Roy O. Greep Award for Outstanding Research
By Glenda Fauntleroy Shaw, Derek Bagley Verified| Endocrine News Verified Barbara Kahn, MD, initially pursued medical school to understand how the human body works and to help patients with chronic illnesses. During her general medicine fellowship, her cross-over study on blood glucose and urine glucose monitoring led to invitations from U.K. researchers to tour their research institutes — a pivotal experience that revealed basic research as an alternate path to her goal of helping people with chronic illnesses live long, gratifying lives.
By Derek Bagley Verified| Endocrine News Verified Last month Corcept Therapuetics Incoporated announced that the U.S. Food and Drug Administration (FDA) filed its New Drug Application (NDA) submission for the company’s proprietary, selective cortisol modulator, relacorilant, to treat patients with endogenous hypercortisolism (Cushing’s syndrome). Corcept’s NDA is based on positive results from the pivotal GRACE trial and confirmatory evidence from the Phase 3 GRADIENT trial, long-term extension trial, and a Phase 2 trial in hypercortisolism.
The Path of Kahn: Q&A with Barbara Kahn, MD, Recipient of the 2025 Roy O. Greep Award for Outstanding Research
By Glenda Fauntleroy Shaw, Derek Bagley Verified| Endocrine News Verified Barbara Kahn, MD, initially pursued medical school to understand how the human body works and to help patients with chronic illnesses. During her general medicine fellowship, her cross-over study on blood glucose and urine glucose monitoring led to invitations from U.K. researchers to tour their research institutes — a pivotal experience that revealed basic research as an alternate path to her goal of helping people with chronic illnesses live long, gratifying lives.
Company Info
Endocrine News
Washington, District of Columbia, United States
+1 202-971-3636